
Nanomedic
Overview: Nanomedic
Nanomedic has introduced the Spincare™ Wound Care System in Europe, a paradigm shift in the treatment of wounds from superficial to hard-to-heal chronic and complex wounds. It is the first and only device of its kind on the market. The Spincare™ System introduces an innovative treatment option into the advanced wound care arena with inherent characteristics and advantages that outperforms traditional wound care methodologies, fits a vast spectrum of wounds and injuries, allowing patients to go about their lives while healing. The unique structure of the matrix will someday contain a variety of additives from antibacterial, collagen and adhesive materials to embedded human cells, treating the most severe and complicated wounds.
The details in this email are based on information received from, and verified solely by, the company.
Nanomedic Management Team
Mark Darty
CEO
Mark Darty has over 30 years’ experience, more than half of which is in medical devices. He held board, senior executive, and key management positions at cutting-edge companies in the medical device, consumer electronics, and aerospace markets including HyperMed Imaging, Luminetx, Brother International, Boeing/McDonnell Douglas, and General Dynamics. Most recently, he was Board Member, CEO, and President of HyperMed Imaging where he led the company from inception to global commercialization of its award-winning medical device for wound care and surgical applications. He has a B.S. in Electrical Engineering and an M.S. in Engineering with over 30 patents.
Dr. Chen Barak
President
Dr. Chen Barak has more than 20 years of proven experience in the development and commercialization of medical devices. She has held multiple managerial positions in the medical device industry at Florence Medical Ltd. and FlowMedic Ltd. Prior to joining Nanomedic, Chen served as the General Manager of Gardia Medical for more than 6 years. Dr. Barak graduated from the Technion Institute in Haifa, Israel and received her Ph.D. in Biomedical Engineering at UT Southwestern, Dallas, TX.
Rottem Baruch
CFO
Over 13 years of experience in accounting and finance in global public and private high tech and industrial companies such as Claroty, Qualitest, Afcon and Electra. Led global team of professionals and implemented various ERP systems. Holds M.B.A (with excellence) from the College of Management and M.A (Law) (with excellence) from Bar Ilan University.
Dr. Claudia Barzilay
CTO
Dr. Barzilay has over 15 years of recognized research and development experience in the field of Pharma, Biotech and Medical Devices. Prior to joining Nanomedic, Claudia served as Project Manager, Scientific Advisory and VP R&D, gaining vast knowledge in Product Development, GLP Regulations, Patent writing and Business Development. She received her Ph.D. in Chemistry from the Technion- Israel Institute of Technology, pursued postdoctoral research at Stanford University, CA- USA and achieved a Researcher and Lecturer position at the Hebrew University.
Daniel Sclar
VP Operations
Mr. Sclar brings over 25 years of management experience to Nanomedic. He served as an operations and logistics manager in the IDF and has held executive positions in the nanotech and medical device industries. Prior to joining Nanomedic, Sclar served as ECO of NonoMaterials Ltd, and VP OP's of CathWorks, Angioslide, DNR BioImaging and others. He has a M.Sc. in Industrial Engineering from the Technion- Israel Institute of Technology and MBA from Ben Gurion University in Beer Sheva, Israel
Asher Zilberstein
VP QA/RA
Mr. Zilberstein has more than 20 years of experience in the establishment and management of quality, and regulation assurance activities in the medical device industry, from the development stage to post-marketing environments. Prior to joining Nanomedic, Asher served as QA/RA leader of Endospan, Valtech Medical (Edwards), West Micro infusion Design Center, Gardia Medical, and others. He has a M.Sc. in Biotechnology from the School of Medicine at the Hebrew University in Jerusalem, Israel.
Chen Katz
Active Chairman
CEO of TechnoPlus Venture, a diversified public investment company, traded on the Tel-Aviv Stock Exchange (TASE: TNPV) since 1999. Possesses extensive experience in managing investments in companies and ventures of all maturity levels